Pfizer to Cut Stake in Haleon — Update
GSK PLC GSK
News
-
Pfizer to Cut Stake in Haleon to 24%
GSK's Endometrial Cancer Treatment Study Shows Combination Potential
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
Vir Biotechnology, GSK Terminate Collaboration on Flu
This grouping of stocks has actually kept up with the Magnificent Seven, and with a lot less risk
23andMe shares slide more than 15% as lower services revenue hits Q3 results
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
23andMe Reports Third Quarter Fiscal 2024 Financial Results
Alector, GSK Get FDA Breakthrough Designation for Latozinemab
GSK’s RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk
GSK Settles Another Zantac Case in California — Update
GSK lifts long-term outlook following launch of blockbuster vaccine in 2023
Trending: GSK Hikes its Sales and Earnings Outlook After Beating Market Views
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales — 2nd Update
GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales — Update
GSK Sales Rose on Shingles Vaccine Growth, RSV Drug Launch
GSK's Omjjara Authorized in EU for Treating Myelofibrosis With Anemia
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology